APREMILAST vs DALIRESP

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 21, 2026·How we rate

Possible drug interaction. APREMILAST and DALIRESP are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	APREMILAST	DALIRESP
Rating	70/100	70/100
Pharmacy pays	—	~$10.09 /30
Type	RX	RX
Active ingredient	APREMILAST	ROFLUMILAST
Manufacturer	Macleods Pharms Ltd	Astrazeneca
Dosage forms	Tablet	Tablet
Drug class	Phosphodiesterase 4 Inhibitor	Phosphodiesterase 4 Inhibitor
Boxed warning	None	None
Half-life	about 6 to 9 hours (terminal elimination half-life)	—
Treats	Psoriatic Arthritis	Chronic Obstructive Pulmonary Disease

apremilast daliresp

Rating

70/100

Pharmacy pays

—

~$10.09 /30

Type

Active ingredient

APREMILAST

ROFLUMILAST

Manufacturer

Macleods Pharms Ltd

Astrazeneca

Dosage forms

Tablet

Drug class

Phosphodiesterase 4 Inhibitor

Boxed warning

None

Half-life

about 6 to 9 hours (terminal elimination half-life)

—

Treats

Psoriatic Arthritis

Chronic Obstructive Pulmonary Disease

Frequently asked questions

Which is better-rated, Apremilast or Daliresp?

Apremilast and Daliresp are tied at 3.5 out of 5 by our independent rating.

What is the difference between Apremilast and Daliresp?

Apremilast contains Apremilast, while Daliresp contains Roflumilast — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.